SYMBOL:

    Up to 100 tickers separated by a space .....Watch Post-Market activities
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
CORTEX PHARMACEUTICALS
(NQPK:CORX Last Sale: .039 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQPK: (CORX : $.039)
$3 million Market Cap at September 12, 2013
Employs 25.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

15241 Barranca Parkway Research Report Earnings Snapshot - Last 05/15/16
Irvine, CA 92618 Fact Sheet
Phone: (949) 727-3157 Financial Statements
Fax: (949) 727-3657 Peer Comparison
Annual Reports

Roger G. Stoll, Chmn./Pres./CEO, M. Messinger, CFO
October 11, 2007, FDA rejected the company's request for a mid-stage study of its attention deficit hyperactivity disorder drug candidate, CX717.
Historical Charts    Technical Analysis
No Historical Data available for CORX

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common CORX $.039 $ 0 $.032 $.039 101,260 $.02 $.099 85,624
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $3,339

A424
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex